⌘K

Login Start Free

Home/Filings/4/0001213900-21-012341

4//SEC Filing

Albanna Amro A. 4

Accession 0001213900-21-012341

CIK 0001726711other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:11 AM ET

Size

4.8 KB

Accession

0001213900-21-012341

Insider Transaction Report

Form 4

Period: 2021-02-24

Aditx Therapeutics, Inc.ADTX

Albanna Amro A.

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Award
Common Stock
2021-02-24+225,000→ 772,220 total

Footnotes (1)

[F1]The restricted common stock shall vest in three (3) successive equal annual installments, beginning on March 31, 2021.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Aditx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1

filerCIK 0001424733

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 6:11 AM ET
Size: 4.8 KB

View on SEC.gov